Regeneron Pharmaceuticals EBIT Margin 2010-2024 | REGN
- Regeneron Pharmaceuticals average ebit margin for 2023 was 33.28%, a 29.07% decline from 2022.
- Regeneron Pharmaceuticals average ebit margin for 2022 was 46.92%, a 9.84% decline from 2021.
- Regeneron Pharmaceuticals average ebit margin for 2021 was 52.04%, a 35.98% decline from 2020.
Ebit margin can be defined as earnings before interest and taxes as a portion of total revenues